Positive Psychotherapy for Smoking Cessation Enhanced With Text Messaging: A Randomized Controlled Trial
1 other identifier
interventional
271
1 country
2
Brief Summary
Positive Psychotherapy for Smoking Cessation (PPT-S) addresses an array of risk factors for poor smoking outcomes (low positive affect, depressive symptoms, and cynical cognitions), while also providing skills that may buffer against stress and negative affect. The overall objective of this project is to conduct a randomized controlled trial to test the efficacy of PPT-S, enhanced with text messaging, compared to a time-matched behavioral smoking cessation treatment. Participants in both treatment conditions will receive nicotine replacement therapy and a validated text-messaging intervention for smoking cessation that monitors progress in quitting smoking and extends smoking counseling outside of the individual face-to-face context.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2016
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 5, 2016
CompletedFirst Posted
Study publicly available on registry
December 20, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 15, 2021
CompletedResults Posted
Study results publicly available
March 1, 2023
CompletedMarch 1, 2023
February 1, 2023
5.2 years
December 5, 2016
December 22, 2022
February 6, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
7-day Point Prevalence Smoking Abstinence at 12 Weeks
Self-reported smoking abstinence biochemically confirmed with CO and cotinine
12 weeks
7-day Point Prevalence Smoking Abstinence at 26 Weeks
Self-reported smoking abstinence biochemically confirmed with CO and cotinine
26 weeks
7-day Point Prevalence Smoking Abstinence at 52 Weeks
Self-reported smoking abstinence biochemically confirmed with CO and cotinine
52 weeks
Continuous Smoking Abstinence
Self-reported continuous abstinence from cigarette smoking from quit date through the 52-week follow-up biochemically confirmed at 12, 26, and 52 weeks
52 weeks
Secondary Outcomes (3)
Engagement in PPT-consistent Quitting Strategies
During treatment - weeks 1-4 after quit date
Residual Attraction to Smoking
At end of treatment (4 weeks after quit date)
Self-efficacy for Resisting Smoking
At end of treatment (4 weeks after quit date)
Study Arms (2)
Positive Psychotherapy for Smoking Cessation
EXPERIMENTALSmoking cessation treatment that incorporates exercises and text messages derived from positive psychology interventions that are designed to boost positive moods, cognitions, and behaviors.
Standard smoking cessation treatment
ACTIVE COMPARATORSmoking cessation counseling that provides support and problem solving skills for avoiding smoking.
Interventions
Exercises designed to boost moods, positive behaviors, and positive cognitions.
Counseling designed to provide support and problem solving for smoking cessation
Eligibility Criteria
You may qualify if:
- be 18 years of age or older
- smoke at least 5 cigarettes per day for longer than one year with no current regular use of other nicotine/tobacco products including e-cigarettes
- have a baseline carbon monoxide level of at least 4 ppm
- be willing to use the nicotine patch
- report at least a 5 on a 0 to 10 scale rating the importance of quitting smoking (where 10 = extremely important);
- have an active cell phone and be willing to send and receive text messages for the duration of the intervention.
You may not qualify if:
- \. Contact study site for details
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Brown Universitylead
- Truth Initiativecollaborator
Study Sites (2)
Partners Healthcare and Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Center for Alcohol and Addiction Studies, Brown University
Providence, Rhode Island, 02912, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Christopher Kahler
- Organization
- Brown University School of Public Health
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher Kahler, PhD
Brown University
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 5, 2016
First Posted
December 20, 2016
Study Start
September 1, 2016
Primary Completion
November 15, 2021
Study Completion
November 15, 2021
Last Updated
March 1, 2023
Results First Posted
March 1, 2023
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share